Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

New research has shown a 39% drop in cancer screenings and a 28% decline in treatments during the pandemic — can global healthcare systems bounce back?

This year's commemoration of World Cancer Day offers a three-year journey to raise awareness about one of the world’s biggest ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...

Innate Pharma (NASDAQ:IPHA – Get Free Report) and Agenus (NASDAQ:AGEN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based ...

A mother of three was blindsided by a cervical cancer diagnosis just days before her 30th birthday — despite experiencing ...

I was mad at God, mad at the world, and mad at all the healthy people who didn’t have to get their life put on hold,” said ...

A new research paper was published in Oncoscience’s Volume 12 on January 20, 2025, titled “Maternal, delivery and neonatal ...

Researchers from The University of Manchester have explored the barriers that block patients from attending their cervical ...

With proper screening, vaccination, and awareness, we can significantly reduce cervical cancer cases. It is crucial to educate people because cervical cancer is one of the few cancers in women ...

A new research paper was published in Oncoscience's Volume 12 on January 20, 2025, titled "Maternal, delivery and neonatal outcomes in women with cervical cancer. A study of a population database." ...